RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $273,000 | +92.3% | 30,434 | +14.9% | 0.00% | – |
| Q2 2016 | $142,000 | -4.1% | 26,485 | -17.0% | 0.00% | – |
| Q1 2016 | $148,000 | +33.3% | 31,911 | +49.1% | 0.00% | – |
| Q4 2015 | $111,000 | -24.0% | 21,403 | -11.3% | 0.00% | – |
| Q3 2015 | $146,000 | -73.3% | 24,119 | -30.3% | 0.00% | – |
| Q2 2015 | $546,000 | +425.0% | 34,598 | +256.9% | 0.00% | – |
| Q1 2015 | $104,000 | +181.1% | 9,694 | +177.7% | 0.00% | – |
| Q4 2014 | $37,000 | +5.7% | 3,491 | -2.9% | 0.00% | – |
| Q3 2014 | $35,000 | -86.6% | 3,597 | -84.1% | 0.00% | – |
| Q2 2014 | $261,000 | +42.6% | 22,574 | +24.0% | 0.00% | – |
| Q1 2014 | $183,000 | +18200.0% | 18,208 | +18108.0% | 0.00% | – |
| Q4 2013 | $1,000 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
| Q3 2013 | $7,025,000 | +9.5% | 470,857 | -31.4% | 0.00% | 0.0% |
| Q2 2013 | $6,414,000 | – | 685,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |